Vinayak Doraiswamy, Chief Scientific Officer at AtriCure, Inc. (ATRC), sold 6,000 shares at $38.88 ($233K) on 2026-07-28, disclosed to the SEC on 2026-07-30.
Seasonal sale ($233k) by Chief Scientific Officer — this insider has traded ATRC in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ATRC | SELL | 2025-08-07 | $91K | — | Filing → |
| ATRC | SELL | 2025-05-30 | $84K | — | Filing → |
| ATRC | SELL | 2022-09-19 | $458K | — | Filing → |